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Abstract
Objective: Neonatal sepsis (NS) is a common and life-threatening disorder in infants. Previousstudies showed that interleukin-6 (IL-6) may be a valid non-invasive and rapid method fordiagnosis of NS. We conducted this review to assess the validity of IL-6 for predicting NS.
Methods: This was a systematic review with meta-analysis. Embase, Medline and Web of Sciencedatabases were searched between January 1990 and December 2009. The search terms used were“cytokine”, “neonate”, “sepsis” and “interleukin-6". We used standard methods recommended formeta analyses of diagnostic test evaluations. The analysis was based on a summary ROC (SROC)curve. Meta-regression analysis was used to assess the effects of some confounding factors on theresults of meta-analysis. Potential presence of publication bias was tested using funnel plots andthe Egger test.
Findings: Meta-analysis was performed on 13 publications including 353 infants with sepsis and691 control infants. The pooled sensitivity and specificity of IL-6 was 0.79 and 0.84, respectively.The maximum joint sensitivity and specificity (i.e., the Q value) in SROC curve was 0.82 and thearea under curve (AUC) was 0.89 (95% CI: 0.84-0.94). Meta-regression analysis showed that thediagnostic accuracy of IL-6 was not affected by confounding variables. The evaluation ofpublication bias showed that the Egger test was not significant (P=0.07).
Conclusion: IL-6 seems to be a valid marker for predicting NS. It may be considered for earlydiagnosis of sepsis in neonatal care units.
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IntroductionNeonatal sepsis (NS) is a common andlife-threatening disorder, especially in pretermInfants [1]. Up to 10% of infants have an infectionin the first month of life [2]. The rate of mortalityand morbidity due to NS is very high [1,2].The prognosis and outcome of NS depend onearly diagnosis and on-time and efficient antibiotictherapy [1]. Diagnosis of neonatal infection may bethe greatest and most difficult challenge for aneonatologist [3]. In most of NS patients, theclinical manifestations are non-specific in earlierstages [4], thus rapid and non-invasive methods fordiagnosis of the infected neonate is important inneonatal care [5].Clinical judgment and laboratory tests such ascomplete blood cell count and the ratio betweenimmature to total neutrophils (I/T ratio) showedto be useful in the early diagnosis of neonatalseptic infection [4]. The microbiological culturesare the gold standard for diagnosis of neonatalsepsis but they are not available until at least up to72h and do not identify most infected infants [1,2].In recent years, chemokines and pro-inflammatory cytokines such as tissue necrosisfactor-alpha (TNF-α), interleukin-6 (IL-6), IL-8 andpro-calcitonin (PCT) have been introduced asearly markers in infected infants [6,7]. IL-6 isproduced by monocytes, endothelial cells andfibroblasts [1]. The concentration of IL-6 risesrapidly after the onset of bacteremia, but its halflife is short [8,9]. Previous studies showed that IL-6may be a valid non-invasive and rapid method fordiagnosis of NS [8,9]. The role of IL-6 in diagnosis ofNS was reviewed in 2000 [6] but it did not includemeta-analysis and could not determine thequantitative value of IL-6 for diagnosis of NS.So, we conducted this systematic review andmeta-analysis to assess the validity of IL-6 forpredicting NS.
Subjects and Methods
Search strategy and study selection:The following electronic databases were searchedbetween January 1990 and December 2009:Embase, Medline and Web of Science. The
Cochrane Library also was reviewed to findrelevant articles.The search terms used were “cytokine”,“neonate”, “sepsis” and “intrleukin-6”. Thereference lists from original and review articleswere also searched. No language restrictions wereconsidered. We excluded conference abstracts andletters to the journal editors because of the limiteddata presented in them. A study was included inthe meta analysis when it was conducted onneonates (1-28 days old). It consisted of at leasttwo groups (culture positive sepsis group andcontrol group); assessed the diagnostic value ofIL6 in neonatal sepsis and provided enough dataallowing test results to be extracted for individualstudy subjects.If an article did not include enough data forcalculating sensitivity and specificity (two by twotable) the corresponding author was asked toprovide us necessary data. In case of no responsefrom the corresponding author, a reminder wassent after 1 week. If necessary data was notavailable after this process, the study wasexcluded from meta-analysis.Studies conducted on special groups ofneonates (neonates with metabolic disorders,hemodialysis, necrotizing enterocolitis andintraventricular hemorrhage) were excluded. Allstudies were checked by two reviewersindependently. Disagreements were resolved byconsensus.
Data extraction and quality assessment:Data collected from the studies includedparticipant characteristics, type of study, samplesize, test methods, sensitivity and specificity data,cutoff values, publication year, and methodologicalquality. The numbers of true-positive, false-positive, false-negative, and true-negative resultswere extracted for each study. If no data on theabove criteria was reported in the primarystudies, we requested the information from theauthors.We assessed the methodological quality of thestudies using guidelines published by the qualityassessment for studies of diagnostic accuracy(QUADAS) tool including 14 questions [10].Questions with “yes”, “no” and “unknown” answerwere scored as 1, -1 and 0, respectively.(maximum score, 14).
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Statistical Analysis:We used standard methods recommended formetaanalyses of diagnostic test evaluations [11].Analyses were performed using STATA version 10and Meta-DiSc for Windows [12]. We computed thefollowing measures of test accuracy for eachstudy: sensitivity; specificity; positive likelihoodratio (PLR); negative likelihood ratio (NLR); anddiagnostic odds ratio (DOR). The analysis wasbased on a summary ROC (SROC) curve [11,13].Sensitivity and specificity for the single testthreshold identified for each study were used toplot an SROC curve [13,14]. A random-effects modelwas used to calculate the average sensitivity,specificity and other measures across studies [15,16].The term heterogeneity when used in relationto meta-analyses refers to the degree of variabilityin results across studies. We used the chi-squareand Fisher exact tests to detect statisticallysignificant heterogeneity.Meta-regression analysis was used to assess theeffects of some factors on the results of meta-analysis. To assess the effects of these factors onthe diagnostic ability of neonatal sepsis, weincluded them as covariates in univariatemetaregression analysis (inverse varianceweighted). The following 5 covariates entered themeta-regression analysis: time of sepsis onset(late onset versus others); study quality(QUADAS≥10 versus others); cut-off level for IL-6assay (≥50 pg/ml versus others); control group
status (healthy control versus others) and birth-weight of the neonates. Considering birth-weight,the neonates were divided into two groups. Thefirst group consisted of neonates with very lowbirth-weight (VLBW) and the second one includedneonates with low or normal birth-weight(others).The relative DOR (RDOR) was calculatedaccording to standard methods to analyze thechange in diagnostic precision in the study perunit increase in the covariate [17,18]. Sincepublication bias is of concern for metaanalyses ofdiagnostic studies, we tested for the potentialpresence of this bias using funnel plots and theEgger test [19].Since the present study was a meta analysis thatwas based on published articles, to include theconsents of patients and the approval of internalreview boards was not applicable.
Findings18 publications (No. 20-37) about the role of IL-6for predicting NS were considered to haveeligibility criteria to be included in the study (Fig.1). We could not find enough data for analyzing 5of 18 studies (Nos. 27, 28, 32, 33 and 35), so, theywere excluded. Finally, 13 publications including
Fig.i1: Flow diagram of the process of identifying and including references for the systematic review
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Table 1: Characteristics of studies dealing with the role of IL-6 for predicting neonatal sepsis
Study/ year Assay method Cut-off
(pg/ml)
Sensitivity
(CI 95%)
Specificity
(CI 95%)
DOR
(CI 95%)
Quality score
(QUADAS)
Buck et al/1994 [20] ELISA 10 0.727
(0.390- 0.940)
0.778
(0.644- 0.880)
9.333
(2.138- 40.750)
8
Ng et al/1997 [21] ELISA 31 0.886
(0.733- 0.968)
0.955
(0.845- 0.994)
162.75
(28.009- 945.68)
13
Berner et al/1998 [22] Double
sandwich EIA
100 0.875
(0.710- 0.965)
0.93
(0.872- 0.968)
93.333
(26.806- 324.97)
11
Kuster et al/1998 [23] ELISA 25 0.857
(0.673- 0.960)
0.85
(0.621- 0.968)
34
(6.723- 171.94)
13
Dollner et al/2001 [24] ELISA 33 0.818
(0.482- 0.977)
0.692
(0.386- 0.909)
10.125
(1.466- 69.935)
11
Krueger et al/2001 [25] ChIIA 80 0.872
(0.726- 0.957)
0.902
(0.837- 0.947)
62.246
(20.729- 186.92)
14
Martin et al/2001 [26] ChIIA 160 0.962
(0.693- 1.000)
0.69
(0.454- 0.871)
55.769
(2.849- 1091.7)
11
Gonzalez et al/2003 [29] ELISA 18 0.667
(0.223- 0.957)
0.81
(0.581- 0.946)
8.5
(1.131- 63.871)
10
Laborada et al/ 2003 [30] ChII 18 0.756
(0.597- 0.876)
0.737
(0.603- 0.845)
8.68
(3.442- 21.890)
12
Santana Reyes et al/
2003 [31]
ELISA 30 0.612
(0.462- 0.748)
0.803
(0.720- 0.871)
6.453
(3.099- 13.439)
13
Verboon-Maciolek et
al/2006 [34]
ChIIA 60 0.676
(0.502- 0.820)
0.759
(0.565- 0.897)
6.548
(2.192- 19.556)
13
Caldas et al/2008 [36] ChIIA 25.8 0.775
(0.615- 0.892)
0.87
(0.664- 0.972)
22.963
(5.537- 95.232)
11
Beceiro Mosquera et
al/2009 [37]
Lateral Flow
Immunoassay
53 0.909
(0.587- 0.998)
0.806
(0.625- 0.925)
41.667
(4.434- 391.56)
9IL: interleukin; DOR: Diagnostic odds ratio; QUADAS: Quality assessment for studies of diagnostic accuracy;ELISA: Enzyme-linked immunosorbent assay; ChIIA: Chemiluminescence immunoassay; EIA= Enzyme immunoassay
353 infants with sepsis and 691 control infantswere analyzed. Table 1 shows summary dataobtained from the studies.
Charachteristics of the studies:In 4 of 13 studies, control groups included healthyneonates. The designs of 6 studies were case-control and the remaining 7 were cross-sectional.In all of 13 studies, both male and female neonateswere included. Mean gestational ages were 32.1(range: 27.1-38.8) and 33.2 (range: 27.7-40)weeks in sepsis and control groups, respectively.Mean birth weights were 1780 (range: 904-3502)and 1927 (range: 1060-3628) grams in sepsis andnon-sepsis neonates, respectively.
Diagnostic accuracy:Table 1 and Fig. 2 show the results from includedstudies on sensitivity and specificity of IL-6 forpredicting neonatal sepsis. PLR ranged from 2.66to 19.47 (pooled, 4.55; 95% CI: 3.27-6.32) whileNLR ranged from 0.06 to 0.48 (pooled, 0.26; 95%CI: 0.18-0.36). The pooled value of DOR was 20.74with 95% CI of 10.83 to 39.7 (ranged from 6.45 to162.75). χ2 values of sensitivity, specificity, PLR,
NLR and DOR were 22.45 (P=0.03), 32.27(P=0.001), 34.12 (P=0.001), 27.02 (P=0.008) and33.96 (P=0.001).We found that the SROC curve is positionednear the upper left corner of the curve, and that
Fig. 2: Forest plot of estimates of sensitivity andspecificity of IL-6 for predicting neonatal sepsis.
●=point estimates of sensitivity and specificity from eachstudy; error bars = 95% CIs; numbers= reference numbers ofstudies cited in the reference list. Pooled estimates were asfollows: sensitivity, 0.79 (95% CI, 0.74 to 0.83); specificity, 0.84(95% CI, 0.81 to 0.87)
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Fig. 3: Summary ROC curve for assessment of thediagnostic accuracy of IL-6 to predict neonatal sepsis.
We found that the SROC curve is positionednear the upper left corner of the curve, and thatthe maximum joint sensitivity and specificity (i.e.,the Q value) was 0.82; and the area under curve(AUC) was 0.89 (95% CI: 0.84-0.94) (Fig. 3).
Meta-regression analysis:The 5 covariates entered into the meta-regressiondid not have significant effect of the diagnosticaccuracy of IL-6 (Table 2).The evaluation of publication bias showed thatthe Egger test was not significant (P=0.07). Thefunnel plots for publication bias also show noasymmetry (Fig. 4). These results indicate nopotential for publication bias.
DiscussionThis meta-analysis was conducted to assess thevalidity of IL-6 for predicting NS. The sensitivity ofIL-6 assay ranged from 0.61 [31] to 0.96 [26]. Martinet al reported the specificity of IL-6 as 0.69, whileit was as high as 0.95 in another study by Ng et al[21]. We found a wide range for DOR of IL-6 (8.5 to162.75). These differences in sensitivity,specificity and DOR of IL-6 for predicting NS maybe due to various factors. Method of study, methodof IL-6 assay, cut-off levels for IL-6 assay, neonatescharacteristics   (e.g. birthweight)   may   be   some
Fig. 4: Funnel plot for the assessment of potentialpublication bias in IL-6 assay.
●=Each study in the metaanalysis; center line = SDOR. Theresult of the Egger test for publication bias was not significant(P= 0.07).possible explanations for the discrepancy. Thediscrepancy in some studies seemed to be due tolow sample size [22,38].The pooled values of sensitivity (0.79),specificity (0.84) and DOR (20.74) showedfavorable accuracy of IL-6 for predicting NS.Laboratory examination in previous studiessimilarly suggested that IL-6 in the umbilical cordblood increases in newborn infants whodeveloped sepsis [39]. The Q value in SROC curvewas 0.82 indicating high overall accuracy of IL-6for predicting NS.The results of meta-regression showed that thediagnostic accuracy of IL-6 for predicting NS wasnot affected by study quality, cut-off levels of IL-6assay, birth-weight of neonates and control groupstatus. Our results also showed no significantpublication bias. So, it can be concluded that theobserved accuracy of IL-6 for predicting NS wasnot confounded by other variables and IL-6 maybe considered as a promising marker for diagnosisof NS. The risks of blood sampling for IL-6assessment are minimal and restricted to the risksof blood sampling. The only relativecontraindication of multiple blood sampling isanemia of prematurity [6]. Previous studiessuggested that the small amount of blood samplerequired for cytokines assessment may notcontribute significantly to the development ofanemia [38]. The major limitation of IL-6 assay,especially manual methods, is the relatively longtime as well as the interobserver error [40].
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Table 2:Metaregression analysis of the effects of some covariates on diagnostic precision of IL-6 forpredicting neonatal sepsisCovariates Numberof studies Coefficient RDOR (CI95%) P value
Time of sepsis onset (late onset) 4 -0.26 0.77 (0.15-3.83) 0.72
Study quality (QUADAS ≥10) 11 0.98 2.65 (0.28-25.1) 0.5
Cut-off level (≥50 pg/ml) 5 -0.88 0.41 (0.09-1.98) 0.24
Birth-weight (VLBW) 3 0.84 2.31 (0.34-5.88) 0.35
Control group status (healthy controls) 4 0.06 1.06 (0.18-6.14) 0.94IL: interleukin; RDOR: Relative diagnostic odds ratio; QUADAS: Quality assessment for studies of diagnostic accuracyVLBW: Very low birth-weight
However, newer automatic methods made themeasurement of interleukins simpler and moreaccurate [41].
ConclusionIn summary, IL-6 is a valid marker for predictingNS. It may be considered for early diagnosis andcontrol of sepsis in neonatal care units.
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